Cardiovascular Pharmacotherapy

  • Types
  • Formats
  • Years
  • Events
  • Communities
  • Special Options

Showing 24 of 1326 results

Universal evidence and contextual pharmacotherapy
ESC Journals
Universal evidence and contextual pharmacotherapy
22 September 2026
See more
Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation
ESC Journals
Colchicine initiated before radiofrequency-induced injury attenuates left atrial inflammation, fibrosis, and susceptibility to atrial fibrillation
11 September 2026
See more
Selective activation of tetrodotoxin-sensitive sodium channels by AaH-II drives arrhythmogenic late Na<sup>+</sup> current in the heart
ESC Journals
Selective activation of tetrodotoxin-sensitive sodium channels by AaH-II drives arrhythmogenic late Na<sup>+</sup> current in the heart
3 September 2026
See more
Incidence and clinical implications of ventricular tachycardia: a population-based approach
ESC Journals
Incidence and clinical implications of ventricular tachycardia: a population-based approach
3 September 2026
See more
Essential antiarrhythmic drug accessibility worldwide: a multi-survey study and comprehensive evaluation of access and supply challenges
ESC Journals
Essential antiarrhythmic drug accessibility worldwide: a multi-survey study and comprehensive evaluation of access and supply challenges
2 September 2026
See more
Response to Lu Li and colleagues
ESC Journals
Response to Lu Li and colleagues
1 September 2026
See more
Pharmacological prevention: too young or too old?
Congress Session
Pharmacological prevention: too young or too old?
31 August 2026
See more
Artificial intelligence in cardiometabolic drug discovery: from molecular insight to regulatory approval
Congress Session
Artificial intelligence in cardiometabolic drug discovery: from molecular insight to regulatory approval
31 August 2026
See more
Cardiometabolic pharmacotherapy and cardiovascular outcomes
Congress Session
Cardiometabolic pharmacotherapy and cardiovascular outcomes
31 August 2026
See more
Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation
Congress Session
Polypharmacy in cardiovascular disease: prioritisation, safety, and implementation
31 August 2026
See more
Therapeutic advancements in type 2 diabetes mellitus
Congress Session
Therapeutic advancements in type 2 diabetes mellitus
31 August 2026
See more
Contemporary beta‑blocker pharmacotherapy
Congress Session
Contemporary beta‑blocker pharmacotherapy
31 August 2026
See more
Implementing novel lipid‑lowering therapies
Congress Session
Implementing novel lipid‑lowering therapies
31 August 2026
See more
Cardiotoxicity of drugs: machine learning and aortic stenosis
Congress Session
Cardiotoxicity of drugs: machine learning and aortic stenosis
31 August 2026
See more
Immunisation and the heart in the post-pandemic era
Congress Session
Immunisation and the heart in the post-pandemic era
30 August 2026
See more
Updates on dual antiplatelet therapy
Congress Session
Updates on dual antiplatelet therapy
30 August 2026
See more
Optimal cardiovascular pharmacotherapy for the frail patient?
Congress Session
Optimal cardiovascular pharmacotherapy for the frail patient?
30 August 2026
See more
Updates on single and combined antithrombotic therapy
Congress Session
Updates on single and combined antithrombotic therapy
30 August 2026
See more
Pharmacotherapy of aldosterone signalling and drug‑related myocardial injury
Congress Session
Pharmacotherapy of aldosterone signalling and drug‑related myocardial injury
30 August 2026
See more
Cardiovascular epidemic: tackling low-density lipoprotein driven cardiovascular risk
Congress Session
Cardiovascular epidemic: tackling low-density lipoprotein driven cardiovascular risk
30 August 2026
See more
Cardiometabolic pharmacotherapy in complex settings
Congress Session
Cardiometabolic pharmacotherapy in complex settings
30 August 2026
See more
Protection and safety in cardio‑oncology
Congress Session
Protection and safety in cardio‑oncology
30 August 2026
See more
Optimising pharmacotherapy in heart failure
Congress Session
Optimising pharmacotherapy in heart failure
30 August 2026
See more
Clinical Case Management: cardiovascular pharmacotherapeutic considerations in cardiovascular-kidney-metabolic
Congress Session
Clinical Case Management: cardiovascular pharmacotherapeutic considerations in cardiovascular-kidney-metabolic
30 August 2026
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources